Literature DB >> 16499992

Chromosome translocations in cancer: computational evidence for the random generation of double-strand breaks.

Francisco J Novo1, José L Vizmanos.   

Abstract

In this article, we show that introns harboring translocation breakpoints in tumors are significantly longer than non-translocated introns of the same genes but are not enriched significantly in sequence elements potentially involved in chromosomal rearrangements. Our findings provide evidence that double-strand breaks, the type of DNA damage that leads to translocations in tumors, are created at random points in the genome, and that sequence elements do not have a widespread role in the localization of these breaks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499992     DOI: 10.1016/j.tig.2006.02.001

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  8 in total

Review 1.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

2.  Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis.

Authors:  Jean-Baptiste Demoulin; Carmen P Montano-Almendras
Journal:  Am J Blood Res       Date:  2012-01-01

3.  Genetic and epigenetic determinants mediate proneness of oncogene breakpoint sites for involvement in TCR translocations.

Authors:  N S D Larmonie; A van der Spek; A J J C Bogers; J J M van Dongen; A W Langerak
Journal:  Genes Immun       Date:  2013-12-05       Impact factor: 2.676

4.  TICdb: a collection of gene-mapped translocation breakpoints in cancer.

Authors:  Francisco J Novo; Iñigo Ortiz de Mendíbil; José L Vizmanos
Journal:  BMC Genomics       Date:  2007-01-26       Impact factor: 3.969

5.  Characterization of chromosomal translocation breakpoint sequences in solid tumours: "an in silico analysis".

Authors:  Aditi Daga; Afzal Ansari; Rakesh Rawal; Valentina Umrania
Journal:  Open Med Inform J       Date:  2015-04-30

Review 6.  Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.

Authors:  Sandrine Medves; Jean-Baptiste Demoulin
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

7.  Fcirc: A comprehensive pipeline for the exploration of fusion linear and circular RNAs.

Authors:  Zhaoqing Cai; Hongzhang Xue; Yue Xu; Jens Köhler; Xiaojie Cheng; Yao Dai; Jie Zheng; Haiyun Wang
Journal:  Gigascience       Date:  2020-06-01       Impact factor: 6.524

8.  Signatures of selection in fusion transcripts resulting from chromosomal translocations in human cancer.

Authors:  Iñigo Ortiz de Mendíbil; José L Vizmanos; Francisco J Novo
Journal:  PLoS One       Date:  2009-03-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.